Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00030628 · ClinicalTrials.gov registry record · Phase 3

Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

A Phase 3 study, sponsored by Alliance for Clinical Trials in Oncology.

Completed
Registry status
Phase 3
Development phase
480
Enrollment target

NCT00030628 is a Phase 3 study that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 480 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00030628, a Phase 3 study, has completed, sponsored by Alliance for Clinical Trials in Oncology.

COMPLETED
Registry status
Phase 3
Development phase
480 participants
Enrollment target

Study Summary

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Radiosurgery may be able to deliver x-rays directly to the tumor and cause less damage to normal tissue. It is not yet known if radiosurgery is more effective with or without whole-brain radiation therapy in treating brain metastases. PURPOSE: Randomized phase III trial to compare the effectiveness of radiosurgery with or without whole-brain radiation therapy in treating patients who have brain metastases.

Interventions

  • RADIATION radiation therapy
  • PROCEDURE surgery
  • RADIATION WBRT

Trial Details

FieldValue
Enrollment Target 480 participants
Start Date 2001-12
Est. Completion 2014-10
Phase Phase 3

What the Registry Record Tells You About NCT00030628

The ClinicalTrials.gov registry entry for NCT00030628 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 480 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which radiation therapy is the first listed.

NCT00030628 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00030628 about?

NCT00030628 is a clinical study titled "Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases". RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Radiosurgery may be able to deliver x-rays directly to the tumor and cause less damage to normal tissue. It is not yet known if radiosurgery is more effective with or without whole-brain radiation therapy in treating brain m...

What is the current status of trial NCT00030628?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 480 participants. The study started on 2001-12. Estimated completion is 2014-10.

What interventions are being tested in trial NCT00030628?

The interventions under investigation include: radiation therapy (RADIATION), surgery (PROCEDURE), WBRT (RADIATION).

Who is sponsoring clinical trial NCT00030628?

This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.